Nordea Investment Management Ab Roivant Sciences Ltd. Transaction History
Nordea Investment Management Ab
- $103 Billion
- Q2 2025
A detailed history of Nordea Investment Management Ab transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Nordea Investment Management Ab holds 406,859 shares of ROIV stock, worth $4.71 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
406,859
Previous 404,075
0.69%
Holding current value
$4.71 Million
Previous $4.08 Million
12.46%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$694 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$517 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$396 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...